HHM Wealth Advisors LLC Takes $254,000 Position in Eli Lilly And Co (LLY)

Share on StockTwits

HHM Wealth Advisors LLC acquired a new stake in Eli Lilly And Co (NYSE:LLY) in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund acquired 2,195 shares of the company’s stock, valued at approximately $254,000.

Several other hedge funds also recently modified their holdings of LLY. FDx Advisors Inc. raised its holdings in Eli Lilly And Co by 48.3% in the 4th quarter. FDx Advisors Inc. now owns 19,504 shares of the company’s stock worth $2,257,000 after purchasing an additional 6,356 shares during the period. State of Alaska Department of Revenue raised its holdings in Eli Lilly And Co by 3.3% in the 4th quarter. State of Alaska Department of Revenue now owns 204,487 shares of the company’s stock worth $23,660,000 after purchasing an additional 6,474 shares during the period. Waverton Investment Management Ltd raised its holdings in Eli Lilly And Co by 1.9% in the 4th quarter. Waverton Investment Management Ltd now owns 12,724 shares of the company’s stock worth $1,472,000 after purchasing an additional 238 shares during the period. Pennsylvania Trust Co raised its holdings in Eli Lilly And Co by 46.4% in the 4th quarter. Pennsylvania Trust Co now owns 85,021 shares of the company’s stock worth $9,839,000 after purchasing an additional 26,947 shares during the period. Finally, Sumitomo Life Insurance Co. raised its holdings in Eli Lilly And Co by 2.7% in the 4th quarter. Sumitomo Life Insurance Co. now owns 30,683 shares of the company’s stock worth $3,551,000 after purchasing an additional 800 shares during the period. 78.69% of the stock is owned by institutional investors and hedge funds.

NYSE:LLY opened at $126.59 on Wednesday. Eli Lilly And Co has a 12 month low of $74.51 and a 12 month high of $130.75. The company has a quick ratio of 1.38, a current ratio of 1.73 and a debt-to-equity ratio of 1.07. The company has a market cap of $129.68 billion, a price-to-earnings ratio of 22.81, a PEG ratio of 2.52 and a beta of 0.33.

Eli Lilly And Co (NYSE:LLY) last posted its quarterly earnings data on Wednesday, February 6th. The company reported $1.33 EPS for the quarter, missing the Thomson Reuters’ consensus estimate of $1.36 by ($0.03). Eli Lilly And Co had a return on equity of 44.66% and a net margin of 13.16%. The firm had revenue of $6.44 billion for the quarter, compared to analysts’ expectations of $6.28 billion. During the same quarter last year, the firm posted $1.14 earnings per share. Eli Lilly And Co’s quarterly revenue was up 4.5% on a year-over-year basis. Equities research analysts forecast that Eli Lilly And Co will post 5.64 earnings per share for the current year.

LLY has been the subject of a number of analyst reports. Cantor Fitzgerald reaffirmed a “buy” rating on shares of Eli Lilly And Co in a report on Monday, February 4th. UBS Group reduced their price target on Eli Lilly And Co from $107.53 to $100.00 and set an “average” rating for the company in a report on Friday, February 8th. Argus reaffirmed a “buy” rating on shares of Eli Lilly And Co in a report on Thursday, December 27th. BMO Capital Markets upped their price target on Eli Lilly And Co from $124.00 to $132.00 and gave the stock an “outperform” rating in a report on Monday, December 24th. They noted that the move was a valuation call. Finally, Citigroup cut Eli Lilly And Co from a “buy” rating to a “neutral” rating and set a $113.00 price target for the company. in a report on Sunday, December 2nd. Ten equities research analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the company. Eli Lilly And Co presently has an average rating of “Buy” and an average target price of $113.06.

In other news, SVP Alfonso G. Zulueta sold 4,000 shares of the company’s stock in a transaction that occurred on Thursday, January 31st. The stock was sold at an average price of $120.00, for a total value of $480,000.00. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, major shareholder Lilly Endowment Inc sold 205,000 shares of the company’s stock in a transaction that occurred on Tuesday, February 19th. The shares were sold at an average price of $122.48, for a total value of $25,108,400.00. Following the completion of the sale, the insider now owns 117,641,684 shares of the company’s stock, valued at $14,408,753,456.32. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 833,190 shares of company stock valued at $102,388,102. 0.11% of the stock is owned by company insiders.

COPYRIGHT VIOLATION NOTICE: This piece of content was originally published by Ticker Report and is owned by of Ticker Report. If you are viewing this piece of content on another domain, it was copied illegally and republished in violation of United States and international trademark and copyright legislation. The legal version of this piece of content can be accessed at https://www.tickerreport.com/banking-finance/4235667/hhm-wealth-advisors-llc-takes-254000-position-in-eli-lilly-and-co-lly.html.

Eli Lilly And Co Company Profile

Eli Lilly and Company discovers, develops, manufactures, and markets pharmaceutical products worldwide. The company operates through two segments, Human Pharmaceutical Products and Animal Health Products. It offers endocrinology products for the treatment of diabetes; osteoporosis in postmenopausal women and men; and human growth hormone deficiency and pediatric growth conditions.

Further Reading: NASDAQ

Want to see what other hedge funds are holding LLY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Eli Lilly And Co (NYSE:LLY).

Institutional Ownership by Quarter for Eli Lilly And Co (NYSE:LLY)

Receive News & Ratings for Eli Lilly And Co Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Eli Lilly And Co and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Pundi X Tops 24 Hour Trading Volume of $3.99 Million
Pundi X Tops 24 Hour Trading Volume of $3.99 Million
PutinCoin Price Tops $0.0002 on Major Exchanges
PutinCoin Price Tops $0.0002 on Major Exchanges
Ulord  1-Day Volume Hits $455,813.00
Ulord 1-Day Volume Hits $455,813.00
BitcoinZ Hits One Day Trading Volume of $149,163.00
BitcoinZ Hits One Day Trading Volume of $149,163.00
Brokerages Set Mr. Cooper Group Inc  Price Target at $15.63
Brokerages Set Mr. Cooper Group Inc Price Target at $15.63
Welbilt, Inc  Given Consensus Recommendation of “Buy” by Brokerages
Welbilt, Inc Given Consensus Recommendation of “Buy” by Brokerages


© 2006-2019 Ticker Report